RxDoctor Payments Data

Renante Ignacio, MD

Geriatric Medicine · Oswego, NYNPI 1861485849

Payments from drug & device makers

$186in general payments, 2019–2025

Across 5 payments — averaging $37.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$78
  • Johnson & Johnson$50
  • Abbott$23
  • Acadia Pharmaceuticals Inc$19
  • Otsuka America Pharmaceutical, Inc.$16

What the payments were for

  • Food & beverage$186100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$186 in reported general payments places this provider in the 60th percentile of 400 geriatric medicine providers in New York.

See all geriatric medicine providers in New York

Medicare billing

Part B allowed, 2024
$222,578
Medicare patients
284
Services billed
2,222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban277$104,856
NuplazidPimavanserin Tartrate20$65,463
VelphoroSucroferric Oxyhydroxide31$52,768
TrulicityDulaglutide54$52,592
XareltoRivaroxaban118$46,058
EntrestoSacubitril/Valsartan43$22,586
JanuviaSitagliptin Phosphate62$16,685
NuedextaDextromethorphan Hbr/Quinidine23$15,423
MyrbetriqMirabegron47$13,525
TradjentaLinagliptin55$11,673
LinzessLinaclotide40$9,902
JardianceEmpagliflozin15$9,438
Combivent RespimatIpratropium/Albuterol Sulfate16$8,315
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,586
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog26$7,501

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$19$65,46320 claims
Johnson & JohnsonXarelto$50$46,058118 claims
Avanir Pharmaceuticals, Inc.Nuedexta$78$15,42323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 400 geriatric medicine providers in New York.

Other geriatric medicine in Oswego

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →